PublizoomAward notice Supplies
Acord-cadru de furnizare antineoplazice
Notice published in Romanian. The AI analysis summarises it for you in your language.
- Public buyer
- SPITALUL CLINIC MUNICIPAL CLUJ-NAPOCA
Cluj-Napoca - Place of performance
- Cluj-Napoca
- Estimated value
- €15,465,509 excl. VAT
- Planned end of contract
- 21 November 2026
likely re-tender around October 2026 - Bids received
- 4
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 1 September 2026
- Notice language
- Romanian
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Achizitie ANTINEOPLAZICE 30 loturi conform caiet sarcini. Autoritatea contractanta va raspunde in mod clar si complet tuturor solicitarilor de clarificari/informatiilor suplimentare in a 10-a zi inainte de termenul limita stabilit pentru depunerea ofertelor. Numar zile pana la care se pot solicita clarificari inainte de data limita de depunere a ofertelor/candidaturilor: 18
Awarded to
30 lots
- AFLIBERCEPTUM fl 25mg/ml- 8 ml (200MG)
- AFLIBERCEPTUM fl 25mg/ml-4ml (100MG)
- AVELUMABUM CONC. PT. SOL. PERF 20mg/ml-10 ml (200mg)
- BEVACIZUMABUM-biosimilar conc pt sol perf 25mg/ml -fl 100 mg
- BEVACIZUMABUM-biosimilar conc pt sol perf 25mg/ml -fl 400 mg
- BEVACIZUMABUM-inovativ conc pt sol perf 25mg/ml -fl 100 mg
- BEVACIZUMABUM-inovativ conc pt sol perf 25mg/ml -fl 400 mg
- BLEOMYCINUM SULFAS pulb. sol inj/perf. 15.000 UI
- CISPLATINUM conc pt sol perf 1 mg/ml-fl 25 ml
- CYCLOPHOSPHAMIDUM CONC. PT. SOL. PERF 500 mg/ml
- CYCLOPHOSPHAMIDUM pulb.pt. sol perf iv 200mg
- DOXORUBICINUM conc pt sol perf 10 mg-fl 5ml
- DOXORUBICINUM conc pt sol perf 100 mg- fl 50 ml
- DOXORUBICINUM conc pt sol perf 20 mg-fl 10ml
- DOXORUBICINUM conc pt sol perf 200 mg-100ml
- DOXORUBICINUM conc pt sol perf 50 mg- fl 25 ml
- DOXORUBICINUM pulb.conc.disp lipozom pt perf 50mg x 2 seturi (cu 3 fl/set)
- DURVALUMABUM CONC. PT. SOL. PERF 50 mg/ml, fl a 2,4 ml conc. (care conţine 120 mg durvalumab)
- DURVALUMABUM CONC. PT. SOL. PERF 50 mg/ml, fl la 10 ml conc. (care conţine 500 mg durvalumab)
- GEMCITABINUM conc pt sol perf 100 mg/ml-fl 15 ml
- IRINOTECANUM 4,3 mg/ml)CONC. PT. DISPERSIE PERF.-10ml
- METHOTREXAT sol inj 5000 mg/50 ml
- ONKO BCG 100 pulbere si solvent pentru suspensie intravezicla
- PEMBROLIZUMABUM conc.pt.sol.perf 25mg/ml-4ml (100mg)
- RAMUCIRUMABUM CONC. PT. SOL. PERF 10mg/ml x 2 fl/cutie
- TRABECTEDINUM PULB. PT.CONC. PT.SOL. PERF 0.25mg
- TRABECTEDINUM PULB. PT.CONC. PT.SOL. PERF 1mg
- TRASTUZUMABUM DERUXTECANUM pulb.pt.conc.pt. sol.perf. 100 mg
- VINBLASTINUM SOL INJ.1mg/ml-10ml
- VINCRISTINUM PULB. PT. SOL. INJ./PERF. I V 1mg-10ml
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33652100
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 602049-2026.